Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor

This publication has 40 references indexed in Scilit:

• The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
  The Journal of Experimental Medicine, 2004
• Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
  Blood, 2004
• Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma
  Journal of Clinical Oncology, 2003
• BAFF: A fundamental survival factor for B cells
  Nature Reviews Immunology, 2002
• Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma
  Blood, 2002
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
  Science, 2002
• Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
  The Journal of Experimental Medicine, 2002
• An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway
  Science, 2001
• Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
  Journal of Clinical Investigation, 2000
• Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population
  The Journal of Experimental Medicine, 2000